NeoGenomics stock forecast
NeoGenomics (NG9) Stock Forecast & Price Target
NG9 Analyst Ratings
NG9 Stock 12 Month Forecast
Average Price Target
CHF20.78▲(0.00% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| David Westenberg | Piper Sandler | CHF17.66→CHF20.18 | buy | ― | Reiterated | 10/30/26 | ||
| Michael Matson | Needham | CHF18.50 | buy | ― | Reiterated | 10/29/26 | ||
| Puneet Souda | Leerink Partners | CHF29.43 | buy | ― | Reiterated | 10/29/26 | ||
| Tycho Peterson | Jefferies | CHF13.87→CHF17.66 | buy | ― | Reiterated | 10/29/26 | ||
| Daniel Brennan | TD Cowen | CHF15.97→CHF19.34 | buy | ― | Reiterated | 10/29/26 | ||
| Lu Li | Bank of America Securities | ― | hold | ― | Reiterated | 10/29/26 | ||
| Mark Massaro | BTIG | CHF23.54 | buy | ― | Upgraded | 10/06/26 | ||
| Bruce Jackson | StoneX | CHF13.45→CHF16.82 | buy | ― | Reiterated | 10/06/26 | ||
| Matt Larew | William Blair | ― | hold | ― | Reiterated | 10/06/26 | ||
| William Bonello | Craig-Hallum | CHF14.29→CHF15.97 | buy | ― | Reiterated | 07/29/26 | ||
| Stephens | CHF13.03 | buy | ― | Reiterated | 04/29/26 | |||
| Guggenheim | ― | hold | ― | Reiterated | 02/17/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| David WestenbergPiper Sandler | BuyReiteratedCHF17.66→CHF20.18 | 10/30/26 | ― | ||
| Michael MatsonNeedham | BuyReiteratedCHF18.50 | 10/29/26 | ― | ||
| Puneet SoudaLeerink Partners | BuyReiteratedCHF29.43 | 10/29/26 | ― | ||
| Tycho PetersonJefferies | BuyReiteratedCHF13.87→CHF17.66 | 10/29/26 | ― | ||
| Daniel BrennanTD Cowen | BuyReiteratedCHF15.97→CHF19.34 | 10/29/26 | ― | ||
| Lu LiBank of America Securities | HoldReiterated | 10/29/26 | ― | ||
| Mark MassaroBTIG | BuyUpgradedCHF23.54 | 10/06/26 | ― | ||
| Bruce JacksonStoneX | BuyReiteratedCHF13.45→CHF16.82 | 10/06/26 | ― | ||
| Matt LarewWilliam Blair | HoldReiterated | 10/06/26 | ― | ||
| William BonelloCraig-Hallum | BuyReiteratedCHF14.29→CHF15.97 | 07/29/26 | ― | ||
| BuyReiteratedCHF13.03 | 04/29/26 | ― | |||
| HoldReiterated | 02/17/26 | ― |
Best Analysts Covering NeoGenomics
Copying Bruce Jackson's trades and holding each position for 3 Months would result in 47.37% of your transactions generating a profit, with an average return of +2.09% per trade.
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +16.15% per trade.
Copying Michael Matson's trades and holding each position for 2 Years would result in 60.87% of your transactions generating a profit, with an average return of +18.64% per trade.
NG9 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 2 | 2 |
| Buy | 7 | 9 | 8 | 9 | 7 |
| Hold | 4 | 4 | 4 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 13 | 12 | 16 | 13 |
In the current month, NG9 has received 9 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. NG9 average Analyst price target in the past 3 months is 20.78.
NG9 Financial Forecast
NG9 Earnings Forecast
Next quarter’s earnings estimate for NG9 is CHF 0.06 with a range of CHF 0.04 to CHF 0.07. The previous quarter’s EPS was CHF 0.06. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NG9 Sales Forecast
Next quarter’s sales forecast for NG9 is CHF 173.84M with a range of CHF 173.09M to CHF 174.33M. The previous quarter’s sales results were CHF 172.72M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

